Sponsor:
Icahn School of Medicine at Mount Sinai
Code:
NCT05968560
Conditions
Clinical High Risk for Psychosis (CHR)
Eligibility Criteria
Sex: All
Age: 14 - 25
Healthy Volunteers: Not accepted
Interventions
CBT Skills Group for CHR Youth
Individual CBT sessions
CBT Skills Group for Families
Brief summary:
Conditions
Clinical High Risk for Psychosis (CHR)
Study ID
NCT05968560
Start date
Jul 21, 2023
Status verified date
Jan, 2026
Completion date
Dec 31, 2026
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 14 - 25
Healthy Volunteers: Not accepted
Enrollment
72 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Group and Family-Based Cognitive Behavioral Therapy (GF-CBT-TH)
experimental: Family-Based Cognitive Behavioral Therapy (F-CBT-TH)
active comparator: Individual Cognitive Behavioral Therapy (I-CBT-TH)
Interventions
CBT Skills Group for CHR Youth
Individual CBT sessions
CBT Skills Group for Families
Primary outcome measure
Central contacts
Locations
Icahn School of Medicine at Mount Sinai
Recruiting
New York, New York, United States, 10029
Contacts
Principal Investigator:
Yulia Landa
Sponsor
Icahn School of Medicine at Mount Sinai
Last update posted
Jan 20, 2026
Last verified
Jan, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-04. This information was provided to ClinicalTrials.gov by Icahn School of Medicine at Mount Sinai on 2026-01-20.